2002

Feb 13, 2002
Guidant Introduces Innovative Next-Generation Products for Use in Beating-Heart Surgery

New Stabilizer Systems Designed to Make Procedure Available to More Patients Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...

Feb 12, 2002
Guidant and Remon to Develop Vascular Endografts with Pressure-Sensing Technology

Will Provide Physicians with a Cost-Effective, Non-Invasive Means to Monitor Aneurysm Pressure Indianapolis, Ind., Menlo Park, Calif., and Caesaria, Israel - Guidant Corporation (NYSE and PCX:...

Feb 11, 2002
Guidant Announces U.S. and European Launch of Advanced Pacing Lead

Designed for Ease of Handling Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announces...

Feb 1, 2002
Guidant President and CEO is Keynote Speaker at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference

Presentation Accessible Via Webcast Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that Ronald W. Dollens,...

Feb 1, 2002
Guidant Announces Filing for European Approval to Market Drug Eluting Stent

ACHIEVE CE Mark Filing Represents Milestone in Guidant's Drug Eluting Stent Efforts Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that the company has filed for CE...

Show per page

Top